Skip to content


We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact us so we can address the problem.

Absolute BlyS

  • Jonathan B Weitzman
Genome Biology20012:spotlight-20010822-01

Published: 22 August 2001


Marginal ZoneBiotechnology CompanyNormal Bone MarrowDramatic LossTumor Necrosis Factor Family

The B-cell cytokine BlyS/BAFF (B-cell activating factor; also referred to as TALL-1, THANK or zTNF4) plays a critical role in B-lymphocyte development. Two receptors for the tumor necrosis factor family of ligands bind to BlyS/BAFF - the B-cell maturation antigen (BCMA) and TAC1. In the August 16 ScienceXpress, two papers from researchers at the Cambridge-based biotechnology company Biogen describe the role of BAFF and its receptors in B-cell function. Thompson et al. identified a third receptor, BAFF-R, on mouse and human B-lymphocytes. They discovered that a mutant mouse line A/WySnJ expressed an aberrant BAFF-R receptor that accounts for its B-cell phenotype (namely, reduction in number of mature peripheral B-cells despite normal bone marrow and peritoneal B1 cells). In an accompanying paper, Schiemann et al. describe the phenotype of mice lacking the BlyS/BAFFgene. The knockout mice had a dramatic loss of follicular and marginal zone B-cells in the spleen and reduced serum antibody levels. The BlyS/BAFF knockout phenotype is similar to that of the A/WySnJ strain, but differs from those of mice lacking BCMA or TAC1. These two studies clearly demonstrate the significance of the Blys/BAFF factor, and its novel receptor BAFF-R, in B-cell development in vivo.


  1. ScienceXpress , []
  2. Biogen , []
  3. BAFF-R, a Novel TNF Receptor That Specifically Interacts with BAFF, []
  4. Phenotypic and genetic characterization of a unique B lymphocyte deficiency in strain A/WySnJ mice.Google Scholar
  5. An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway, []


© BioMed Central Ltd 2001